{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:22:30Z","timestamp":1793132550349,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ym0126081h0003"],"award-info":[{"award-number":["24ym0126081h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00827-7","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:46:04Z","timestamp":1773665164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enterococcus faecalis KU-EF-004 enhances efficacy of anti-CTLA-4 immunotherapy for colorectal cancer via dendritic cell activation and gut microbiota modulation"],"prefix":"10.1186","volume":"27","author":[{"given":"Taiki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aori","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihoko","family":"Yanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017 ;18,1182\u201391.","journal-title":"Lancet Oncol"},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ et al. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair\u2013Deficient\/Microsatellite Instability\u2013High Metastatic Colorectal Cancer. JCO 2018 ;36, 773\u20139.","journal-title":"JCO"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/1078-0432.CCR-11-1469","volume":"18","author":"FA Sinicrope","year":"2012","unstructured":"Sinicrope FA, Sargent DJ. Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications. Clin Cancer Res. 2012;18:1506\u201312.","journal-title":"Clin Cancer Res"},{"key":"827_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med"},{"key":"827_CR5","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2010.28.3994","volume":"28","author":"Y Ki","year":"2010","unstructured":"Ki Y, Chung I. Lawrence Fong. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. J Clin Oncol. 2010;28:3485\u201390.","journal-title":"J Clin Oncol"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079\u201384.","journal-title":"Science"},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti\u2013PD-L1 efficacy. Science. 2015;350:1084\u20139.","journal-title":"Science"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","volume":"19","author":"AE Frankel","year":"2017","unstructured":"Frankel AE. Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia. 2017;19:848\u201355.","journal-title":"Neoplasia"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science. 2018;359:97\u2013103.","journal-title":"Science"},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137.","journal-title":"Science"},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, et al. The commensal microbiome is associated with anti\u2013PD-1 efficacy in metastatic melanoma patients. Science. 2018;359:104\u20138.","journal-title":"Science"},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13073-019-0672-4","volume":"11","author":"BA Peters","year":"2019","unstructured":"Peters BA, et al. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients. Genome Med. 2019;11:61.","journal-title":"Genome Med"},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1126\/science.aaf3552","volume":"353","author":"KJ Rangan","year":"2016","unstructured":"Rangan KJ, et al. A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens. Science. 2016;353:1434\u20137.","journal-title":"Science"},{"key":"827_CR14","doi-asserted-by":"crossref","unstructured":"Pedicord VA, et al. Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance. Sci. Immunol. 2016;1:eaai7732.","DOI":"10.1126\/sciimmunol.aai7732"},{"key":"827_CR15","doi-asserted-by":"crossref","unstructured":"Kim, B. et al. Enterococcus faecium secreted antigen A generates muropeptides to enhance host immunity and limit bacterial pathogenesis. eLife. 2019 ;8,e45343.","DOI":"10.7554\/eLife.45343"},{"key":"827_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira S, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359:1156\u201361.","journal-title":"Science"},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.aax3760","volume":"366","author":"CK Stein-Thoeringer","year":"2019","unstructured":"Stein-Thoeringer CK, et al. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019;366:1143\u20139.","journal-title":"Science"},{"key":"827_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.572633","volume":"8","author":"C Romyasamit","year":"2020","unstructured":"Romyasamit C, et al. Enterococcus faecalis isolated from infant feces inhibits toxigenic Clostridioides (Clostridium) difficile. Front Pediatr. 2020;8:572633.","journal-title":"Front Pediatr"},{"key":"827_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.abc9113","volume":"373","author":"ME Griffin","year":"2021","unstructured":"Griffin ME, et al. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Science. 2021;373:1040\u20136.","journal-title":"Science"},{"key":"827_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369:1481\u20139.","journal-title":"Science"},{"key":"827_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127262","volume":"10","author":"MA Molina","year":"2015","unstructured":"Molina MA, et al. Immunostimulatory effects triggered by Enterococcus faecalis CECT7121 probiotic strain involve activation of dendritic cells and interferon-gamma production. PLoS One. 2015;10:e0127262.","journal-title":"PLoS One"},{"key":"827_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S0007114512001225","volume":"109","author":"FS Weill","year":"2013","unstructured":"Weill FS, et al. Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis. Br J Nutr. 2013;109:457\u201366.","journal-title":"Br J Nutr"},{"key":"827_CR23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nri1246","volume":"3","author":"ML Kapsenberg","year":"2003","unstructured":"Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3:984\u201393.","journal-title":"Nat Rev Immunol"},{"key":"827_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nri3447","volume":"13","author":"SG Tangye","year":"2013","unstructured":"Tangye SG, Ma CS, Brink R, Deenick EK. The good, the bad and the ugly \u2014 TFH cells in human health and disease. Nat Rev Immunol. 2013;13:412\u201326.","journal-title":"Nat Rev Immunol"},{"key":"827_CR25","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00262-011-1054-y","volume":"60","author":"M Ankathatti Munegowda","year":"2011","unstructured":"Ankathatti Munegowda M, Deng Y, Mulligan SJ, Xiang J. Th17 and Th17-stimulated CD8\u2009+\u2009T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity. Cancer Immunol Immunother. 2011;60:1473\u201384.","journal-title":"Cancer Immunol Immunother"},{"key":"827_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","volume":"31","author":"N Martin-Orozco","year":"2009","unstructured":"Martin-Orozco N, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31:787\u201398.","journal-title":"Immunity"},{"key":"827_CR27","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.4049\/jimmunol.178.11.6730","volume":"178","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007;178:6730\u20133.","journal-title":"J Immunol"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","volume":"170","author":"SC Wei","year":"2017","unstructured":"Wei SC, et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell. 2017;170:1120-1133.e17.","journal-title":"Cell"},{"key":"827_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41571-018-0006-2","volume":"15","author":"V Bertrand Routy","year":"2018","unstructured":"Bertrand Routy V, Romain Daill\u00e8re. The gut microbiota influences anticancer immunosurveillance and general health. Nat Reviews Clin Oncol. 2018;15:382\u201396.","journal-title":"Nat Reviews Clin Oncol"},{"key":"827_CR30","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1158\/2159-8290.CD-21-0929","volume":"12","author":"H Kawanabe-Matsuda","year":"2022","unstructured":"Kawanabe-Matsuda H, et al. Dietary Lactobacillus -Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy. Cancer Discov. 2022;12:1336\u201355.","journal-title":"Cancer Discov"},{"key":"827_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56661-y","volume":"9","author":"Q Zhuo","year":"2019","unstructured":"Zhuo Q, et al. Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model. Sci Rep. 2019;9:20128.","journal-title":"Sci Rep"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00827-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:21:00Z","timestamp":1776903660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00827-7","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and methods were performed in accordance with the relevant guidelines and regulations, and all experimental protocols, including animal experimental designs and procedures, were reviewed and approved by the institutional ethics and animal welfare committees of the Kobe University Graduate School of Medicine. This study is reported in accordance with the ARRIVE guidelines (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}